McLaren and MindMaze race to the future

By SharpBrains | November 5, 2019

_____ F1’s McLaren Rac­ing Extends Neu­rotech­nol­o­gy Part­ner­ship With Mind­Maze (Sport­Techie): “For­mu­la 1 team McLaren Rac­ing has signed a mul­ti-year part­ner­ship with Swiss neu­rotech­nol­o­gy firm Mind­Maze to con­tin­ue test­ing neu­rosens­ing tech­nol­o­gy on its dri­vers. MindMaze’s com­bi­na­tion of vir­tu­al real­i­ty, motion cap­ture and EEG brain scans has previously 

Read More

Washington Wizards to test virtual reality system to better monitor players’ fatigue

By SharpBrains | February 20, 2019

___ Wash­ing­ton Wiz­ards Part­ner With Neu­rotech­nol­o­gy Com­pa­ny To Assess Play­er Fatigue (Forbes): “Pro­fes­sion­al sports teams are always look­ing for an edge, as games are often won or lost by one quick deci­sion or one regret­ful error. As the sports world become recep­tive to tech­nolo­gies more preva­lent in oth­er sec­tors, the new knowl­edge gained can enhance…

Read More

FDA clears MindMaze GO neurorehabilitation platform, easing access to continued outpatient therapy

By SharpBrains | June 13, 2018

___ Mind­Maze Con­sol­i­dates First-ever FDA Approval for Inpa­tient and Out­pa­tient Neu­rore­ha­bil­i­ta­tion Ther­a­py (press release): “Mind­Maze, a leader in brain­tech, has today announced that it has obtained FDA clear­ance to launch its portable neu­rore­ha­bil­i­ta­tion prod­uct, Mind­Mo­tion™ GO, in the Unit­ed States. Togeth­er with Mind­Mo­tion PRO (which received FDA clear­ance in 2017), Mind­Mo­tion GO is the next…

Read More

Lifestyle and neurotechnology over genetics

By SharpBrains | May 31, 2018

?” Dear col­league, It’s remark­able how quick­ly things are chang­ing, final­ly, in brain health and men­tal health — see for exam­ple what’s new with Inter­ax­on, Akili, Neu­raMetrix, Apple, Calm, Halo Neu­ro­science, Mind­strong Health, Novar­tis, Pear Ther­a­peu­tics, and life­long neu­ro­ge­n­e­sis, all in the last 6 months! Please enjoy the May edi­tion of Sharp­Brains eNewslet­ter below, and con­sid­er join­ing the…

Read More

Initial study finds promise and limitations in using virtual reality (VR) to treat ADHD

By Dr. David Rabiner | May 9, 2018

___ Giv­en the lim­i­ta­tions of exist­ing evi­­dence-based ADHD treat­ments, i.e., stim­u­lant med­ica­tion and behav­ior ther­a­py — research on nov­el inter­ven­tion approach­es con­tin­ues to be impor­tant. Cog­ni­tive train­ing is one such approach that has been sug­gest­ed as a poten­tial adjunct or even replace­ment for med­ica­tion treat­ment. While cog­ni­tive train­ing takes dif­fer­ent forms, e.g., com­put­er­ized atten­tion training,…

Read More